Latest News

by Robert MacKay, Thursday, 25 October 2012 | Categories: Slimming Pills

We previously reported that Contrave could gain approval from the FDA if Orexigen Therapeutics were able to demonstrate in a clinical trial that the treatment was not related to cardiovascular problems...




by Robert MacKay, Thursday, 25 October 2012 | Categories: Obesity

One of the most consistent criticisms of the current food labelling systems in the UK has been that there is not a uniform version that can be found in every supermarket regardless of the food supplier...




by Robert MacKay, Tuesday, 23 October 2012 | Categories: Qnexa | Qsiva

We previously reported that Vivus Inc did not feel confident about its obesity treatment, Qsiva (previously known as Qnexa) being approved for marketing in the EU...




The many benefits of sleep include helping individuals with alertness as well as cognitive abilities such as memory and concentration...




by Robert MacKay, Friday, 19 October 2012 | Categories: Influenza

The research of bird flu has been controversial for a long time, and nine months ago new findings prompted scientists to place a voluntary moratorium on research...





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close